Project Grant R03AI190276
Award Date
6/6/25
Completion Date
5/31/27
Dollars Obligated
$164K
Federal Agency
National Institute of Allergy and Infectious Diseases
Federal Grant Program
93.855
Assistance Type
Project Grant
Place of Performance
미국 뉴욕
Similar Awards
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $178,932 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of Maryland, Baltimore. The award will fund research to analyze the differentiation and function of Vγ9Vδ2 (Vδ2) T cells in cord blood samples using advanced single-cell sequencing techniques such as CITE-Seq and ATAC-Seq. The goal is to better understand the significance of the PD1 inhibitory receptor in...
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded a $781,367 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Weill Medical College of Cornell University. The grant, awarded on January 25, 2024, will support research to define and maximize the impact of CD8+ T-cell selection on the landscape of HIV integration sites. The goal is to optimize strategies for eradicating the persistent reservoir of HIV-infected cells and achieve...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $414,682 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to the University of California, Merced. The grant funding, which runs from June 10, 2025 to May 31, 2028, supports research to investigate the DNA binding dynamics and oligomerization of sensors in the PYHIN family of pattern recognition receptors, specifically the proteins AIM2 and IFI16. The research aims to define the...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $693,465 Project Grant to Cornell University to conduct research on mapping the development of T cell immunity in lymph nodes from infancy to adulthood. The research aims to provide a comprehensive molecular atlas of how T cell activation and priming processes change throughout childhood, with the goal of enhancing immunity and improving vaccine...
The National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded a $649,053 Project Grant (R01AI182141) to The Washington University to conduct research on the role of Ly49 family receptors on CD8 T cells. The research aims to investigate the functional contribution of Ly49 receptors to CD8 regulatory T cells (Tregs) and the role of IL-15 and the transcription factor Helios in the development and function of...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $642,056 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Trustees of Columbia University in the City of New York to study the functional significance of plasma cell infiltrates in cardiac allograft vasculopathy (CAV). The goal is to characterize the plasma cells infiltrating cardiac allografts during CAV, determine the function of the antibodies they produce, and assess the...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $639,084 Project Grant (CFDA 93.855 - Allergy and Infectious Diseases Research) to the Children's Hospital Medical Center in Cincinnati, Ohio. The grant funding, which runs from March 2025 to February 2030, will support research to elucidate the heterogeneity of naive CD8 T cells and understand how this contributes to immune responses and T cell homeostasis in mice. The research also aims to define a human naive CD8 T...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $711,993 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Boston Medical Center Corporation. The grant, awarded on June 11, 2025, will fund research to investigate the effects of Mycobacterium tuberculosis (MTB) disease on HIV-1 immunity, evolution, and persistence. The research aims to understand how MTB disease impacts the development of broadly potent HIV-1 neutralizing...
This federal Project Grant award in the amount of $806,693.00 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research at New York University School of Medicine to investigate the role of the lymphatic vasculature in regulating germinal center immune responses. The research aims to elucidate the mechanisms governing lymphangiogenesis during inflammation and determine how...
This $1,486,800 Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research by Albert Einstein College of Medicine into antibody-dependent cell-mediated cytotoxicity (ADCC) for vaccine development against herpes simplex virus (HSV). The project aims to investigate the role of TNFRSF14 signaling in promoting ADCC responses and develop new strategies for future vaccine and...